Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation
Twist Bioscience Is Maintained at Buy by TD Cowen
Twist Bioscience Is Maintained at Buy by TD Cowen
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $65
TD Cowen analyst Steven Mah maintains $Twist Bioscience(TWST.US)$ with a buy rating, and maintains the target price at $65.According to TipRanks data, the analyst has a success rate of 25.8% and a tot
Express News | Twist Bioscience Corp : TD Cowen Raises Target Price to $65 From $55
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $65
TD Cowen analyst Steven Mah maintains $Twist Bioscience(TWST.US)$ with a buy rating, and adjusts the target price from $55 to $65.According to TipRanks data, the analyst has a success rate of 25.8% an
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $45
Barclays analyst Luke Sergott maintains $Twist Bioscience(TWST.US)$ with a buy rating, and maintains the target price at $45.According to TipRanks data, the analyst has a success rate of 42.3% and a t
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Agios Pharmaceuticals Inc (NASDAQ:AGIO) shares soared 29.13% in the last week after reporting that its transf
Correction to Twist Bioscience Headline, Article on May 3
Twist Bioscience's shares rose 25% on a narrower-than-expected second-quarter loss. "Twist Biosciences Shares Rise 25% on Narrower-Than-Expected 2Q Loss," at 12:56 p.m. ET May 3, misspelled the compan
Twist Bioscience Preclinical Data Detailing Discovery Of Antibody Targeting Emerging Checkpoint Inhibitor Published In The Journal PLOS ONE
TB206-001 shown to be a high-affinity, cross-reactive humanized antibody antagonist of A2AR with in vivo tumor suppressing activityTB206-001 available for out-licensingTwist Bioscience Corporation (NA
Guggenheim Starts Twist at Buy, Cites Proprietary DNA Synthesis Platform
Express News | Twist Bioscience Shares Are Trading Higher After Guggenheim Initiated Coverage on the Stock With a Buy Rating and Announced a Price Target of $53
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts
Throughout the last three months, 6 analysts have evaluated Twist Bioscience (NASDAQ:TWST), offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview of re
Twist Bioscience Initiated at Buy by Guggenheim
Twist Bioscience Initiated at Buy by Guggenheim
Express News | Guggenheim Initiates Coverage On Twist Bioscience With Buy Rating, Announces Price Target of $53
Guggenheim Initiates Twist Bioscience With Buy Rating, $53 Price Target
Twist Bioscience (TWST) has an average outperform rating and a price target range of $28 to $55, according to analysts polled by Capital IQ. Price: 43.50, Change: -0.51, Percent Change: -1.16
Form 144 | Twist Bioscience(TWST.US) Officer Proposes to Sell 800.46K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 3, $Twist Bioscience(TWST.US)$ Officer Banyai William intends to sell 18,777 shares of its common stock on Jun 3, with a total market value of approximately $800.46K. Ban
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be
Even Though Twist Bioscience (NASDAQ:TWST) Has Lost US$154m Market Cap in Last 7 Days, Shareholders Are Still up 193% Over 1 Year
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right stock, you can make a lot more than 100%. For example, the Twist Bioscience Corporati
Twist Bioscience to Present at Upcoming Investor Conferences
No Data